Status:
Enrolling

A Multi-Modal Remote Monitoring Platform for Frontotemporal Lobar Degeneration (FTLD) Syndromes

Phase
Not Specified
Age
40-89
Sponsor
Massachusetts General Hospital
Enrollment code
60
Last Updated
Nov 20, 2024
Locations
2 Countries

Overview

Condition/disease
Dementia
Modalities
Device
Trial drugs
[not applicable] 
Clinicaltrials.gov ID

Brief summary

The primary objective of this study is to enroll an observational cohort of approximately 60 patients with PSP over the course of 24 months using a multicenter study design and to follow each of them for 12 months.

The secondary objective of this study is to develop a robust solution for multi-modal remote monitoring of motor symptoms and function in PSP that can be applied to other Frontotemporal lobar degeneration (FTLD) syndromes.

Trial locations

Found 2 sites

Johns Hopkins School of Medicine

USA - MD - Baltimore

Massachusetts General Hospital

USA - MA - Boston

Eligibility criteria

Inclusion criteria:

  • Clinical diagnosis of possible or probable PSP as defined by the 2017 MDS criteria
  • Fluent in reading and speaking English and capable of providing informed consent based on the principal investigator's judgement
  • Able to walk 10 feet unassisted at the time of initial enrollment
  • Must have a caregiver or study partner who is willing and able to assist with all study-related procedures

Exclusion criteria:

  • Any neurological, medical, or psychiatric condition that would preclude participation in study activities based on the investigator's judgment.
  • A history of frequent falls defined as more than 5 falls per month, or who require a walker to ambulate safely at baseline will not be eligible to participate in the study.

Outcome measures

Primary outcome measures

  • Feasibility (12 months)

Secondary outcome measures

  • PSPRS (12 months)
  • Cortical Basal ganglia Functional Scale (CBFS) (12 months)

More information

Official title

A Multi-Modal Remote Monitoring Platform for Frontotemporal Lobar Degeneration (FTLD) Syndromes

Estimated trial completion date

Dec 30, 2026
Not finding what you’re looking for?
If you’re having trouble using this website or can’t find what you’re looking for, please call us at 1-855-329-5969. Our team is here to help you find your way.
Get notifications directly in your inbox
Sign up to get tailored email notifications about trials of interest to you.
Sign up for alerts
Stay connected with PAN
As you explore the world of clinical trials, we invite you to join the larger PAN family.
Join our email list